FFM
MRK icon

Fullerton Fund Management’s Merck MRK Stock Holding History

Fullerton Fund Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$435K Sell
3,618
-6,733
-65% -$777K 0.03% 75
2025
Q4 		$1.09M Buy
+10,351
New +$972K 0.05% 38
2024
Q2 		– Sell
-2,909
Closed -$384K – 164
2024
Q1 		$384K Buy
+2,909
New +$359K 0.02% 102

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fullerton Fund Management's MRK Position: Q1 2026 in Review

Fullerton Fund Management reduced its Merck (MRK) stake by 65% in Q1 2026, selling an estimated $777K and leaving 3,618 shares worth $435K. The position accounts for 0.03% of the portfolio, ranked #75.

Fullerton Fund Management first reported a position in MRK in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.09M in Q4 2025. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fullerton Fund Management held 3,618 shares of Merck worth $435K as of Q1 2026.
  • Fullerton Fund Management sold 6,733 Merck shares in Q1 2026, an estimated $777K.
  • Merck made up 0.03% of Fullerton Fund Management's portfolio in Q1 2026, its #75 holding.
  • Fullerton Fund Management first reported a position in Merck in Q1 2024 and has held it in 3 quarters since.
  • Fullerton Fund Management's Merck position peaked at $1.09M in Q4 2025.
  • 3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fullerton Fund Management's 13F filing for Q1 2026, filed 15 May 2026.